文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

连续性肾脏替代治疗期间低白蛋白血症的恶化或改善可预测患者结局:单中心回顾性研究

Worsening or improving hypoalbuminemia during continuous renal replacement therapy is predictive of patient outcome: a single-center retrospective study.
PubMed 文献 · J Intensive Care · 2022-06-07
一句话结论CRRT期间血清白蛋白持续低或下降者院内死亡率更高,白蛋白升高或持续高者死亡率更低,监测变化模式有助于预测结局。

该单中心回顾性研究纳入2016年1月至2020年12月接受CRRT≥72小时的急性肾损伤患者793例,根据CRRT启动和终止时血清白蛋白水平(≥3.0 g/dL或<3.0 g/dL)分为持续低、升高、下降、持续高四组。院内死亡率在持续低和下降组最高,其次为升高和持续高组;与持续低组相比,升高组院内死亡风险比为0.481(0.340-0.680);与持续高组相比,下降组风险比为1.911(1.394-2.620)。持续低组ICU住院时间比持续高组长3.55天。作者认为监测CRRT期间白蛋白变化模式有助于预测院内死亡率和ICU住院时间。

要点

  • 793例接受CRRT≥72小时的AKI患者中,持续低白蛋白组占37.7%(299例),下降组占24.6%(195例),升高组占10.4%(85例),持续高组占27.1%(214例)。
  • 院内死亡率在持续低和下降组最高,其次为升高和持续高组。
  • 与持续低组相比,升高组院内死亡风险比为0.481(0.340-0.680);与持续高组相比,下降组风险比为1.911(1.394-2.620)。
  • 持续低组ICU住院时间比持续高组长3.55天。
  • 作者认为监测CRRT期间血清白蛋白变化模式有助于预测院内死亡率和ICU住院时间。

适用人群与场景

  • 2016年1月至2020年12月在第三附属医院连续收集的接受CRRT≥72小时的急性肾损伤患者。

诊断标准与关键阈值

  • 根据CRRT启动和终止时血清白蛋白水平(≥3.0 g/dL或<3.0 g/dL)将患者分为四组:持续低(两次均<3.0 g/dL)、升高(启动时<3.0 g/dL且终止时≥3.0 g/dL)、下降(启动时≥3.0 g/dL且终止时<3.0 g/dL)、持续高(两次均≥3.0 g/dL)。

研究设计与关键结果

  • 单中心回顾性研究,纳入793例接受CRRT≥72小时的急性肾损伤患者,根据CRRT启动和终止时血清白蛋白水平(≥3.0 g/dL或<3.0 g/dL)分为四组。
  • 分组构成:持续低组299例(37.7%)、升高组85例(10.4%)、下降组195例(24.6%)、持续高组214例(27.1%)。
  • 院内死亡率在持续低和下降组最高,其次为升高和持续高组。
  • 与持续低组相比,升高组院内死亡风险比为0.481(0.340-0.680);与持续高组相比,下降组风险比为1.911(1.394-2.620)。
  • 持续低组ICU住院时间比持续高组长3.55天。

证据类型、等级与局限

  • 证据类型:单中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,监测CRRT期间血清白蛋白水平的变化模式有助于预测院内死亡率和ICU住院时间。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Hypoalbuminemia at the initiation of continuous renal replacement therapy (CRRT) is a risk factor for poor patient outcomes. However, it is unknown whether the patterns of changes in serum albumin levels during CRRT can be used to predict patient outcomes.

METHODS: This retrospective study analyzed data that had been consecutively collected from January 2016 to December 2020 at the Third Affiliated Hospital. We included patients with acute kidney injury who received CRRT for ≥ 72 h. We divided the patients into four groups based on their serum albumin levels (albumin ≥ 3.0 g/dL or < 3.0 g/dL) at the initiation and termination of CRRT.

RESULTS: The 793 patients in this study were categorized into the following albumin groups: persistently low, 299 patients (37.7%); increasing, 85 patients (10.4%); decreasing, 195 patients (24.6%); and persistently high, 214 patients (27.1%). In-hospital mortality rates were highest in the persistently low and decreasing groups, followed by the increasing and persistently high groups. The hazard ratio for in-hospital mortality was 0.481 (0.340-0.680) in the increasing group compared to the persistently low group; it was 1.911 (1.394-2.620) in the decreasing group compared to the persistently high group. The length of ICU stay was 3.55 days longer in the persistently low group than in the persistently high group.

CONCLUSIONS: Serum albumin levels changed during CRRT, and monitoring of patterns of change in serum albumin levels is useful for predicting in-hospital mortality and the length of ICU stay.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Rhee H, Jang GS, Kim S, et al. Worsening or improving hypoalbuminemia during continuous renal replacement therapy is predictive of patient outcome: a single-center retrospective study. J Intensive Care. 2022. PMID: 35672868. doi:10.1186/s40560-022-00620-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。